OBJECTIVES: To investigate the relationships of fat cell weight (FCW) as well as of estimated total adipose cell number to fasting plasma leptin concentration. DESIGN: Cross-sectional correlational study. SUBJECTS: A sample of 63 men (mean age AE s.d.: 36 AE 4 y) and 42 premenopausal women (35 AE 5 y). MEASUREMENTS: Adipose tissue (AT) biopsies were obtained in order to determine FCW as well as estimated adipose cell number. Fasting plasma leptin and insulin concentrations as well as various fatness and body fat distribution variables (underwater weighing and computed tomography) were also measured. RESULTS: In both genders, mean FCW as well as the estimated adipose cell number were signi®cantly correlated with body fatness and AT distribution variables (0.41 r 0.84). Larger abdominal (P`0.005) and femoral (P`0.0001) FCW were found in women than in men. This gender difference in adipose cell size was associated with increased leptin concentrations in women compared with men. In both genders, increased abdominal FCW was associated with higher plasma leptin concentrations (men: r 0.38, P`0.005 and women: r 0.55, P`0.0001). However, the association between femoral FCW and leptinemia was only signi®cant in women (r 0.45, P`0.005). Contrary to women, plasma leptin concentrations were associated with estimated adipose cell number in men (r 0.59, P`0.0001). Multiple regression analyses revealed that gender (43.3%), mean FCW (16.2%) and the estimated adipose cell number (10.1%) were signi®cant predictors of fasting leptinemia. CONCLUSIONS: Results of the present study indicate that in men and women, adipose cell hypertrophy is associated with increased plasma leptin concentrations. This ®nding provides further support to the observation that adipose tissue leptin secretion may be regulated, at least to a certain extent, by adipocyte size. Thus, the present study suggests that the higher plasma leptin concentrations found in women than in men could be partly explained by the well documented gender difference in adipose cell size and number.
Introduction
The discovery of leptin has been an important breakthrough in the understanding of the regulation of energy balance. 1 Indeed, when administered to obese leptin-de®cient mice (obaob), leptin has been shown to lower body weight by reducing food intake and increasing energy expenditure. 1 ± 7 Concordant with the observation that the ob gene is almost exclusively expressed in adipose tissue (AT), 8 ± 12 numerous studies have reported a strong relationship between adiposity and plasma leptin concentrations or adipose tissue ob mRNA levels. 13 ± 21 In humans, a gender difference, which is partly independent of adiposity, has been noted in plasma leptin concentrations with women characterized by higher leptin levels than men. 21 ± 26 Although it has been suggested that sex steroid hormones may be implicated in this gender difference, 27 with androgens tending to decrease leptin levels 28 ± 30 and estrogens increasing leptinemia, 31 they do not seem to be the only factors responsible for this discrepancy. A regional difference in ob gene expression has been reported, ie adipocytes from subcutaneous depots produce more leptin than fat cells obtained from intraabdominal depots. 15, 32, 33 ln addition, it has been suggested that fat cell size could be an important contributor to leptin secretion by the AT as smaller adipocytes are characterized by lower expression of the ob gene and secretion of leptin compared to larger fat cells. 14, 34 As women are generally characterized by larger adipocytes and by greater estimated total number of adipose cells compared to men, 35 ± 39 we examined the potential relationships between subcutaneous abdominal as well as femoral fat cell weight (FCW), the estimated adipose cell number, and plasma leptin concentrations in both men and women. Results of the present study indicate that fat cell size has a greater impact on plasma leptin concentrations than the estimated total number of adipose cells. However, both adipocyte hypertrophy and, to a lesser extent, adipose cell hyperplasia contribute to the higher plasma leptin concentrations found in women compared with men.
Methods

Subjects
Sixty-three men (mean age AE s.d.: 36 AE 4 y) and 42 premenopausal women (35AE 5 y) were recruited through the media to participate in this study, which was approved by the Medical Ethics Committee of Laval University. An informed consent document was signed by all participants. A complete physical examination, which also included medical history, was performed by a physician. All participants were nonsmokers and free from diseases requiring treatment. Exclusion criteria included diabetes, monogenic dyslipidemias, evidence for the presence of coronary heart disease as well as use of medication known to affect carbohydrate and lipid metabolism.
Anthropometric measurements
Weight and height were measured following the procedures recommended at the Airlie Conference. 40 Body density was measured by the hydrostatic weighing technique, 41 and the mean of six measurements was used in the calculation of body density. Percentage body fat was obtained from body density using the equation of Siri. 42 
Computed tomography
Computed tomography (CT) was performed on a Siemens Somatom DRH scanner (Erlagen, Germany) using previously described procedures. 43, 44 Brie¯y, the subjects were examined in the supine position with both arms stretched above the head. A single CT scan was performed at the abdominal level (between L4 and L5 vertebrae) with a scout abdominal radiograph used as a reference to establish the position of the scan to the nearest millimeter. Total AT area was calculated by delineating the area with a graph pen and then computing the AT surface with an attenuation range of À190 to À30 Houns®eld Units. 43 ± 45 The abdominal visceral AT area was measured by drawing a line within the muscle wall surrounding the abdominal cavity. The abdominal subcutaneous AT area was calculated by subtracting the visceral AT area from the total abdominal AT area.
Adipose tissue biopsies and determination of adipose cell size and number Following skin anesthesia with 1% xylocaine, 1 cm incisions were performed in the abdominal and femoral regions, and AT was surgically removed. After collection, AT was quickly transferred to the laboratory, in saline (0.9% NaCl) ± HEPES (5 mM), pH 7.4. Adipocytes were isolated according to the method of Rodbell 46 in Krebs ± Ringer bicarbonate buffer (pH 7.4) containing 4% bovine serum albumin (KRBA) and 5 mM glucose, plus 1 mgaml collagenase as already described. 47 Digestion took place in shaking water bath under a gas phase of 95% O 2 and 5% CO 2 , for 40 min at 37 C. The suspension was then ®ltered and the cellular ®ltrate obtained was rinsed three times with 5 ml KRBA. Isolated adipocytes were ®nally resuspended in KRBA, to obtain a ®nal concentration of approximately 500 cells per 50 ml. Adipose cell diameters were determined using a Leitz microscope equipped with a graduated ocular (Rockleigh, New Jersey, USA). Mean fat cell diameter was assessed from the measurement of b 500 cells, and the density of triolein was used to transform adipose cell volume into fat cell weight, as previously described. 47 Validation of our collagenase isolation methodology against adipose cell size obtained by electron microscopy study revealed that our procedure was not associated with the selective rupture of large fat cells. 48 Thus, our average adipose cell size represents the volume of the mature fat cells. Total adipose cell number was estimated using the following equation:
Total body fat mass kg Abdominal FCW mg femoral FCW mg Â 0X5
Although this index may not completely re¯ect interindividual and regional differences in adipocyte size, we must emphasize the fact that biopsies were obtained from two major subcutaneous fat depots (ie abdominal and femoral) that are likely to re¯ect variation in subcutaneous adipose cell size and number. The absolute total number of mature adipose cells is certainly underestimated as it is well known that intraabdominal adipocytes are smaller in size than subcutaneous fat cells. 49 However, we are convinced that for a given amount of total body fat, the obese patients with small subcutaneous adipocytes (abdominal femoral) have more mature fat cells than the obese patients with large subcutaneous adipocytes. This is the simple rationale on which the present analyses are based.
Plasma insulin and leptin concentrations
Blood samples were collected through a venous catheter from an antecubital vein in the morning after a 12 h fast, and plasma insulin was measured by RIA with polyethylene glycol separation. 50 Plasma leptin concentrations were determined with a commercially available double-antibody radioimmunoassay (RIA; Human Leptin Speci®c MA Kit, LINCO Research, St Louis, Missouri, USA) which detects leptin levels down to 0.5 ngaml and which does not crossreact with human insulin, proinsulin, glucagon, Adipose cell hypertrophy and hyperleptinemia C Couillard et al pancreatic polypeptide or somatostatin. Our coef®-cients of variation for the repeated assays ranged from 4.0 to 5.5% for lower leptin concentrations and from 6.5 to 8.5% for higher plasma leptin concentrations.
Statistical analyses
Student t-tests were used to examine gender differences in FCW, total body estimated adipose cell number and other variables. Pearson product ± moment correlation coef®cients were used to examine associations among variables. A multiple regression analysis was also performed to estimate the independent contribution of gender, mean FCW as well as the estimated adipose cell number to the variation in fasting plasma leptin concentrations. In a second analysis, we replaced mean FCW by abdominal and femoral FCW. All analyses were performed with the SAS statistical package (SAS Institute, Cary, North Carolina, USA). Table 1 shows the subjects' physical characteristics. There was a signi®cant gender difference in bodyfatness as women had higher BMI, percentage of body fat and total body fat mass values compared with men. We also observed the expected differences in body fat distribution between men and women. Men were characterized by an increased abdominal visceral AT accumulation, while women displayed higher levels of subcutaneous fat in the abdominal region. This increased adiposity found in women was also accompanied by signi®cantly higher abdominal and femoral FCW compared to men. A trend for an increased estimated number of adipocytes was noted in women, but this difference did not reach statistical signi®cance (P 0.07). As body fatness and plasma leptin concentrations are closely related, we also noted a signi®cant and expected gender difference in leptinemia. Indeed, women showed plasma leptin levels that were three times as high as those noted in men.
Results
Relationships of FCW as well as the estimated adipose cell number to total body fatness and AT distribution variables are presented in Table 2 . Both the estimated adipose cell number and FCW were positively correlated with all body fatness and AT distribution indices in both men and women.
Relationships of mean FCW to fasting plasma insulin as well as leptin concentrations are shown in Table 3 . In both genders, mean FCW was positively associated with plasma insulin and leptin concentrations, although the associations were stronger in women than in men probably because of the greater variation in fatness in the former than in the latter subjects. Elevated plasma insulin was correlated with an increased estimated adipose cell number in both genders. However, while men showed a signi®cant association between the estimated fat cell number and leptinemia, this association was not found in women. When abdominal and femoral FCW were studied Adipose cell hypertrophy and hyperleptinemia C Couillard et al separately (Figure 1 ), we found that abdominal FCW was positively associated with plasma insulin and leptin concentrations in both genders. However, femoral FCW was associated with plasma insulin and leptin concentrations only in women. We have performed multiple regression analyses in order to quantify the independent contributions of gender, mean FCW and estimated adipose cell number to the variation in fasting plasma leptin levels (Table 4) . Mean FCW (16.2%) and the estimated adipose cell number (10.1%) both contributed signi®cantly to the variance in leptinemia. However, in our study, gender was by far the best predictor of plasma leptin concentrations explaining 43.3% of its variation. It is also relevant to point out that after control for the above variables, fasting insulin concentration did not contribute signi®cantly to the variance in leptinemia. In a second analysis, mean FCW was taken out of the model and replaced by abdominal and femoral FCW. Again, gender was the strongest correlate of plasma leptin concentration (38%), followed by abdominal FCW (15.8%) and the estimated fat cell number (4.4%). No signi®cant independent contribution was found for femoral FCW.
As body fat mass is closely related to FCW and to estimate adipose cell number, we have not included this variable (body fat mass) in the previous multiple regression analyses. However, we have also conducted additional analyses in which we included total body fat mass as an independent variable in addition to FCW and estimated adipose cell number. These analyses revealed that fat mass was the second best (15.2%) correlate of plasma leptin concentration after gender (38%). In that model, mean FCW (2.8%) and estimated fat cell number (5.0%) were also signi®cant independent contributors to the variation in plasma leptin concentrations. Furthermore, when we replaced mean FCW by both abdominal and femoral FCW, the results obtained were similar to those of the ®rst multiple regression analysis, ie that FM was not a signi®cant predictor of the variance in plasma leptin concentrations.
Discussion
Gender differences in body fatness and in indices of AT distribution found in the present study have been well documented. 21 In the present study, a gender difference in adipocyte size was found as women had Figure 1 Associations of abdominal fat cell weight (FCW; left panels) and femoral FCW (right panels), expressed in mg lipidacell, with plasma insulin (top panels) and leptin (bottom panels) concentrations in 63 men (black circles) and 42 women (white circles).
Adipose cell hypertrophy and hyperleptinemia C Couillard et al increased FCW both in the abdominal and femoral regions compared with men This observation is also concordant with previous results from our laboratory and from other groups. 35 ± 39 Although signi®cant associations between FCW and body fatness were found in both genders, the relationship of adiposity to femoral FCW was weaker in men compared with women. This is not surprising, considering that men are generally characterized by abdominal obesity and also by a lower subcutaneous fat deposition than women. 51 ± 53 Abdominal obesity has also been associated with hyperinsulinemia. 51, 53 Accordingly, in the present study, increased abdominal FCW was associated with higher plasma insulin and leptin concentrations in both men and women. However, associations between femoral FCW and plasma insulin as well as leptin levels were only signi®cant in women. Since plasma leptin concentrations have not been reported to be associated with regional AT distribution, 21, 26, 54, 55 we believe that the reduced AT accumulation in the femoral region in men may account for the absence of relationship found in our male subjects. Overall, our observations support the notion that fat cell size is an important correlate of leptinemia. 14, 34 On the other hand, AT hyperplasia was also associated with hyperleptinemia, but this association was only signi®cant in men. Since adipocytes are generally smaller in men than in women, 35 ± 39 our results suggest that, in men, variation in estimated adipose cell number may have a greater impact on leptinemia in men than in women. Further studies will be necessary to further explain this phenomenon.
The mechanism by which an enlarged adipocyte would produce more leptin is not well known.
In the present study, plasma insulin concentrations were associated with abdominal FCW in both men and women. In addition, insulin has been reported to up-regulate the ob gene expression 3, 12, 56, 57 and to be positively associated with plasma leptin concentration. 13 ± 58 On the other hand, in our study, men were characterized by increased visceral AT accumulation while women had a greater abdominal subcutaneous fat deposition. Visceral adipose cells have been shown to be more resistant to the action of insulin than subcutaneous adipocytes. Thus, despite hyperinsulinemia, it is possible that the insulin resistant visceral fat depot produces less leptin than the insulin sensitive subcutaneous fat. Indeed, studies have suggested that leptin production in the adipose cell may be more closely related to its metabolic state than to its size. For instance, the stimulation of lipolysis of adipose cell down regulates the ob gene expression (energy mobilization), 59 ± 62 whereas fat accumulation and inhibition of lipolysis by insulin could increase leptin production, thus sending a signal to the brain that there is accumulation of energy in AT.
The present study suggests that adipose cell size is a better correlate of plasma leptin concentration than the estimated fat cell number. However, the present study was not designed to identify which mechanism(s) is (are) responsible for such a relationship. Furthermore, in the present study, despite signi®cant contributions of abdominal FCW and estimated AT cell number to fasting leptinemia, gender was by far the best predictor of plasma leptin concentrations explaining 38% of its variance. This ®nding suggests that, in addition to FCW and adipose cell number, other unidenti®ed factors are likely to be implicated in the regulation of leptin production and secretion by AT. Exclusion of gender from the multiple regression analyses revealed that AT mass was the major factor responsible for the contribution of gender to leptinemia (data not shown). Thus, results of the present study also suggest that irrespective of the type of fat accumulation found (hypertrophic or hyperplastic), excess fatness per se is associated with higher leptin levels. In addition, further studies on the role of insulin and steroid hormones in the regulation of leptin are needed, as they have both been shown to in¯uence the ob gene expression. 3,12,28 ± 31,56,57 In these analyses, we did not include total body fat mass in the statistical model as we believe that it was too closely correlated with FCW and estimated adipose cell number (r % 0.75). However, in an additional analysis where mean FCW (either total or abdominal and femoral) and estimated fat cell number were included along with fat mass, all variables Adipose cell hypertrophy and hyperleptinemia C Couillard et al contributed signi®cantly to the variance in leptinemia. Thus, these results suggest that FCW and estimated fat cell number may add further information to the gender difference in plasma leptin levels than what is explained by total body fat mass alone. In summary, results of the present study indicate that increased abdominal (in both men and women) as well as femoral FCW (in women only) are associated with hyperleptinemia. These results suggest that variation in fat cell size may have a signi®cant impact on AT leptin production and secretion. As women are characterized by larger adipocytes than men, this phenomenon may explain, at least in part, the gender difference in leptinemia. Furthermore, our results also suggest that plasma leptin concentration is more closely associated with abdominal FCW than with the estimated adipose cell number. However, the hyperplastic/hypertrophic nature of AT accounts for only a fraction of the variation in leptinemia. Other factors are closely involved and additional studies are needed to better understand the mechanisms responsible for the substantially higher plasma leptin levels noted in women compared with men.
